A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study. [electronic resource]
Producer: 20160802Description: 120-8 p. digitalISSN:- 1097-6744
- Acute Coronary Syndrome -- drug therapy
- Adenosine -- administration & dosage
- Adolescent
- Adult
- Aspirin -- administration & dosage
- Clopidogrel
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Therapy, Combination
- Factor Xa Inhibitors -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Platelet Aggregation Inhibitors -- administration & dosage
- Prospective Studies
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Rivaroxaban -- administration & dosage
- Ticagrelor
- Ticlopidine -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.